Clinical Trials Browser

Acquired Immunodeficiency Syndrome, Alzheimer Disease, Appendicitis, Arthritis, Bronchitis, Bulimia, Cardiovascular Diseases, Cellulitis, Depression, Diabetes Mellitus, Dyspepsia, Eczema, Fibrosis, Gout, Heart Diseases, Hypercholesterolemia, Hypersensitivity, Infections, Infectious Mononucleosis, Influenza, Human, Intestinal Diseases, Leukemia, Liver Diseases, Alcoholic, Neoplasms, Obesity, Osteoporosis, HIV Infections, Renal Insufficiency, Chronic

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Phase 2 Withdrawn

Other hematologic neoplasm

Infectious Mononucleosis, Hematologic Neoplasms

NCT05225493 2022-02-04

#AwareHIV

Unknown

1,500 enrolled

Classical hematologyGynecologic

Lymphadenopathy, Acquired Immunodeficiency Syndrome, Candidiasis, Uterine Cervical Dysplasia, Herpes Zoster, Infectious Mononucleosis, Leukopenia, Pneumonia, Psoriasis, Dermatitis, Seborrheic, Thrombocytopenia, Sexually Transmitted Diseases, Viral, Weight Loss, HIV Infections

NCT03650231 2018-08-28

DIAGEPS

Completed

91 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00359411 2017-07-02

Genetic Studies of X-linked Lymphoproliferative Disease

Completed

12 enrolled

Lymphoid

Infectious Mononucleosis, Lymphoproliferative Disorders, Lymphoma, B-Cell, Epstein-Barr Virus Infections, Genetic Diseases, X-Linked

NCT00575185 2017-03-22

Mono6

Phase 1/2 Completed

23 enrolled 8 charts

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Phase 1/2 Completed

20 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00430534 2007-02-02

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Phase 2 Completed

200 enrolled

Infections, Infectious Mononucleosis, Epstein-Barr Virus Infections

Clinical Trials

Genetic Studies of Chronic Active Epstein-Barr Disease

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

IMMUC

Early Detection of Epstein-Barr Virus Related Disease.

MUC-CFS

BRANCH-P

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

#AwareHIV

DIAGEPS

Genetic Studies of X-linked Lymphoproliferative Disease

Mono6

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).